Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK

Oxazole compound as multi-targeted inhibitor of IRAK4 and BTK

US Patent 12459940 · Granted Nov 4, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluorovinylbenzamide compound as PD-L1 immunomodulator2025
Fluorovinylbenzamide compound as PD-L1 immunomodulator2025
Fluorovinylbenzamide compound as PD-L1 immunomodulator2025
Method and device for schedule an unmanned vehicle2025
Fused-cyclic pyrazolone formamide compound and preparation method therefor, phar2025
Compound as highly selective ROS1 inhibitor and use thereof2025
Compound as highly selective ROS1 inhibitor and use thereof2025
Compound as highly selective ROS1 inhibitor and use thereof2025
Compound as highly selective ROS1 inhibitor and use thereof2025
Tetranectin-targeting monoclonal antibodies to fight against lethal sepsis and o2025
ROR1 specific chimeric antigen receptors and their therapeutic applications2025
Nanophotonics phased-array system for virtual and augmented reality multifocal d2025